|

Multiple Sclerosis Clinical Trials in Los Angeles, CA

15 recruiting studies within 50 miles

Phase
Trial Phase Dist.
Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention StudyPhase 2<1 mi
TSC Biosample Repository and Natural History Database—<1 mi
MS-ResearchBiomarkerS—<1 mi
Study of COYA 302 for the Treatment of ALSPhase 2/3<1 mi
Central Vein Sign in Multiple Sclerosis Extension StudyN/A<1 mi
A Study of Orelabrutinib in Patients With Primary Progressive Multiple SclerosisPhase 37 mi
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple SclerosisPhase 37 mi
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)—7 mi
Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple SclerosisPhase 37 mi
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple SclerosisPhase 37 mi
Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of UblituximabPhase 329 mi
A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic DiseasesPhase 135 mi
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.Phase 336 mi
The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot StudyN/A36 mi
Entire-body PET Scans for Multiple SclerosisEarly 148 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.